268,000 Rocket Lab Corporation $RKLB Shares Purchased by TB Alternative Assets Ltd.

TB Alternative Assets Ltd. grew its stake in shares of Rocket Lab Corporation (NASDAQ:RKLB) by 508.5% during the third quarter, Holdings Channel reports. The institutional investor owned 320,703 shares of the rocket manufacturer’s stock after buying an additional 268,000 shares during the period. Rocket Lab comprises 4.6% of TB Alternative Assets Ltd.’s holdings, making the stock its 7th biggest position. TB Alternative Assets Ltd.’s holdings in Rocket Lab were worth $22,347,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in RKLB. Reflection Asset Management bought a new position in shares of Rocket Lab during the 4th quarter valued at approximately $30,000. Meeder Asset Management Inc. bought a new stake in Rocket Lab during the 2nd quarter worth approximately $30,000. Highland Investment Advisors LLC bought a new stake in Rocket Lab during the 2nd quarter worth approximately $30,000. NBH Bank bought a new stake in Rocket Lab during the 2nd quarter worth approximately $30,000. Finally, Cherry Tree Wealth Management LLC purchased a new position in Rocket Lab during the second quarter valued at approximately $32,000. 71.78% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Rocket Lab

In related news, CFO Adam Spice sold 140,157 shares of the company’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $70.82, for a total transaction of $9,925,918.74. Following the completion of the transaction, the chief financial officer owned 1,155,967 shares in the company, valued at approximately $81,865,582.94. This represents a 10.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Marvin Clevenger sold 15,051 shares of the firm’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $1,048,001.13. Following the transaction, the insider directly owned 458,924 shares of the company’s stock, valued at $31,954,878.12. The trade was a 3.18% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 400,749 shares of company stock valued at $26,964,474. 8.40% of the stock is owned by corporate insiders.

Rocket Lab Stock Down 6.6%

Shares of RKLB opened at $55.25 on Friday. The business’s 50 day moving average is $69.50 and its 200 day moving average is $84.29. The company has a market capitalization of $33.06 billion, a PE ratio of -204.62 and a beta of 2.93. Rocket Lab Corporation has a 12-month low of $37.57 and a 12-month high of $151.00. The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01.

Rocket Lab (NASDAQ:RKLB) last posted its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. The business had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. Research analysts expect that Rocket Lab Corporation will post -0.20 earnings per share for the current fiscal year.

Key Stories Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab reported record second-quarter revenue of approximately $234 million, up 62% year over year, supported by its Electron launch business, satellite operations and defense-related contracts. The company also reportedly has a backlog of about $2.4 billion. Rocket Lab Still Has a $2.4B Backlog While Neutron Waits
• Positive Sentiment: Several analysts remained constructive despite the setback. TD Cowen reaffirmed a Buy rating with a $90 price target, while Roth Capital maintained a Buy rating and a $110 target. These targets imply significant potential upside from recent levels. Stay Cool, Says Analyst About Rocket Lab Stock
• Neutral Sentiment: Rocket Lab’s broader business remains active, including Electron and HASTE launches, spacecraft components and government and defense programs. However, investors are increasingly focused on whether the company can execute its longer-term growth strategy while Neutron development continues.
• Negative Sentiment: Rocket Lab moved Neutron’s inaugural launch to 2027 from its prior fourth-quarter 2026 target. The delay followed a manufacturing flaw in a carbon-composite propellant-tank dome; the company plans additional repairs and testing before setting a launch date. Neutron is strategically important because management’s path to positive adjusted EBITDA depends heavily on the program’s progress. Rocket Lab pushes Neutron rocket’s debut flight to 2027, shares fall
• Negative Sentiment: The setback heightened concerns about execution risk, cash burn and competition with SpaceX. KeyBanc and Clear Street reportedly reduced their price targets, while prior equity issuance to help fund the Iridium acquisition and continued insider selling added to the stock’s overhang. RKLB Stock Alert: What to Know as Rocket Lab Announces Neutron Launch Delay

Analyst Upgrades and Downgrades

A number of research firms have weighed in on RKLB. TD Cowen reiterated a “buy” rating and issued a $90.00 price target on shares of Rocket Lab in a research report on Thursday. Morgan Stanley restated an “overweight” rating on shares of Rocket Lab in a research report on Wednesday, July 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Rocket Lab in a research report on Thursday. KGI Securities upgraded shares of Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 target price on the stock in a research note on Monday, July 27th. Finally, Raymond James Financial began coverage on shares of Rocket Lab in a report on Friday, September 11th. They issued an “outperform” rating and a $80.00 target price for the company. Three research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Rocket Lab currently has a consensus rating of “Moderate Buy” and a consensus price target of $104.05.

About Rocket Lab

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.